Dan Madesclaire

apEXDan Madesclaire

31-Year-Old
Vitality
Horrific in win
CS2Vitality
February 6, 2023
apEX fell to a 31/57/21 KDA during Monday's 2-1 win over Fnatic in IEM Katowice.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Read More News
Counter-Strike 2 Tournament Stats
Loading Counter-Strike 2 Stats...
Counter-Strike 2 Match Log
Calculate Stats Over Time
Just click on any two dates.
Loading Match Log...
Counter-Strike 2 Map Log
Calculate Stats Over Time
Just click on any two dates.
Loading Match Log...
Roster History / Event Placements
  • March 31, 2020
    Joined Vitality
  • March 31, 2020
    Left G2
  • March 4, 2018
    IEM Katowice - Finished 9/12 with G2
  • February 25, 2018
    StarLadder & i-League StarSeries Season 4 - Finals - Finished 5/8 with G2
  • January 28, 2018
    ELEAGUE Major Boston: The New Champions Stage - Finished 5/8 with G2
  • January 22, 2018
    ELEAGUE Major Boston: The New Legends Stage - Finished 1st with G2
  • January 15, 2018
    ELEAGUE Major Boston: The New Challengers Stage - Finished 2nd with G2
More Fantasy News
Bounce back in sweep
CS2Vitality
January 21, 2023
apEX earned a 27/21/11 KDA during Saturday's 2-0 sweep of EG in BLAST Premier Spring Groups.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Laughable in elimination
CS2Vitality
December 16, 2022
apEX fell to a 39/62/17 KDA during Friday's 2-1 loss to G2 in BLAST Premier World Final.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Awful in loss
CS2Vitality
December 15, 2022
apEX tallied a 14/41/13 KDA during Thursday's 2-0 loss to OG in BLAST Premier World Final.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Poor in defeat
CS2Vitality
November 6, 2022
apEX struggled to a 15/23/6 KDA during Sunday's 19-17 loss to MOUZ in IEM Rio Major.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Awful in loss
CS2Vitality
November 1, 2022
apEX fell to a 13/20/9 KDA during Tuesday's 16-12 loss to Outsiders in IEM Rio Major.
ANALYSIS
Subscribe now to instantly reveal our take on this news.